Vascular endothelial growth factor immunoexpression in oral paracoccidioidomycosis
- PMID: 39864089
- PMCID: PMC11972650
- DOI: 10.4317/medoral.26886
Vascular endothelial growth factor immunoexpression in oral paracoccidioidomycosis
Abstract
Background: Paracoccidioidomycosis (PCM) is a systemic mycosis endemic and limited to Latin America. Brazil is responsible for more than 80% of diagnosed cases in the world. Since PCM is not a notifiable disease, there are still no accurate data on its incidence in Brazil. Vascular endothelial growth factor (VEGF) is considered the main vascular endothelial growth factor expressed in the process of angiogenesis, both under physiological and pathological conditions. To date, there are not studies in the literature that evaluated the expression of VEGF in oral PCM lesions. Therefore, the objective of this study was to evaluate the prevalence of oral lesions of PCM diagnosed from 1998 to 2020; to analyze the immunoexpression of VEGF in oral lesions of PCM; and to compare the VEGF immunostaining with the clinical and microscopic aspects of these lesions.
Material and methods: Clinical data of 98 cases of patients with oral PCM were evaluated. A total of 41 selected cases were quantitatively and qualitatively analysed by immunohistochemistry for VEGF.
Results: Our results showed that oral PCM preferentially affects white males, with mean age of 50.2 years, and the gingiva and the alveolar ridge. It was not possible to correlate VEGF immunoexpression with clinical and microscopic variables.
Conclusions: Oral PCM is a relatively uncommon pathological condition and that, in our sample, the immunoexpression of VEGF was mild and observed in a reduced number of cases.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures


Similar articles
-
M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis.J Oral Pathol Med. 2016 Feb;45(2):141-7. doi: 10.1111/jop.12333. Epub 2015 Jun 3. J Oral Pathol Med. 2016. PMID: 26041558
-
Oral paracoccidioidomycosis: Retrospective analysis of 55 Brazilian patients.Mycoses. 2017 Aug;60(8):521-525. doi: 10.1111/myc.12622. Epub 2017 Apr 19. Mycoses. 2017. PMID: 28422366
-
Oral paracoccidioidomycosis: a retrospective study of 95 cases from a single center and literature review.Med Oral Patol Oral Cir Bucal. 2023 Mar 1;28(2):e131-e139. doi: 10.4317/medoral.25613. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36806021 Free PMC article. Review.
-
The relation between FoxP3⁺ regulatory T cells and fungal density in oral paracoccidioidomycosis: a preliminary study.Mycoses. 2014 Dec;57(12):771-4. doi: 10.1111/myc.12226. Epub 2014 Aug 15. Mycoses. 2014. PMID: 25124479
-
A multicentre study of oral paracoccidioidomycosis: Analysis of 320 cases and literature review.Oral Dis. 2018 Nov;24(8):1492-1502. doi: 10.1111/odi.12925. Epub 2018 Aug 6. Oral Dis. 2018. PMID: 29949225 Review.
References
-
- Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. Neglected endemic mycoses. Lancet Infect Dis. 2017;17:367–77. - PubMed
-
- Verli FD, Marinho SA, Souza SC, Figueiredo MA, Yurgel LS. Perfil clínico-epidemiológico dos pacientes portadores de paracoccidioidomicose no Serviço de Estomatologia do Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul. Rev Soc Bras Med Trop. 2005;38:234–7. - PubMed
-
- Caixeta CA, de Carli ML, Ribeiro-Júnior NV, Sperandio FF, Nonogaki S, Nogueira DA. Estrogen receptor-alfa correlates with higher fungal cell number in oral paracoccidioidomycosis in women. Mycopathologia. 2018;183:785–91. - PubMed
-
- Almeida OP, Jorge-Júnior J, Scully C. Paracoccidioidomycosis of the mouth: an emerging deep mycosis. Crit Rev Oral Biol Med. 2003;14:377–83. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical